Etern BioPharma (Shanghai) Co., Ltd
3 clinical trials · Sponsor
◉ Watch Etern BioPharma (Shanghai) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors (NCT05525559) | Etern BioPharma (Shanghai) Co., Ltd | 2022-11-01 |
| FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors (NCT05522309) | Etern BioPharma (Shanghai) Co., Ltd | 2022-08-30 |
| SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors (NCT05354843) | Etern BioPharma (Shanghai) Co., Ltd | 2021-10-27 |
Track Etern BioPharma (Shanghai) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.